Definitive Contract W81XWH21C0003
- Not listed
- This federal contract award to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah, is for the development of COVID-19 assays. The $2,384,846.07 contract was awarded on February 14, 2020 by the U.S. Army's Joint Project Executive Office for Chemical and Biological Defense, a defense agency. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type and an ultimate completion date of July 1, 2022. This award is associated with a larger...
- This is a $15,958,895.53 cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract is to advance the development of the Biofire Emerging COV Panel, a nucleic acid amplification test panel for use on the Biofire FilmArray 2.0 and FilmArray Torch molecular diagnostic platforms. This contract aligns with ASPR's mission to support the...
- The U.S. Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $417,450 firm-fixed-price delivery order to Biofire Defense LLC, a for-profit limited liability company and manufacturer, for the purchase of COVID-19 assays. This award is not associated with a set-aside program. Biofire Defense has previously provided a range of biological agent identification products, diagnostic assays, and testing platforms to various federal agencies, including...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm-fixed-price purchase order to Biofire Defense LLC, a for-profit limited liability company that manufactures biological identification products. The $12,186.00 contract is for the delivery of 30 Respiratory Panel 2.1 in vitro diagnostic tests. The work will be performed in Salt Lake City, Utah and is expected to be completed by May 2, 2024. Biofire Defense has previously received other federal...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call order awarded to Biofire Defense LLC, a small business manufacturer of biological agent identification products and diagnostic solutions. The $8,306.53 contract was awarded by the Bureau of Administration, a civilian agency, for BIOFIRE LAB TEST KITS AND PRODUCTS. The award has a completion date of September 1, 2025 and is set aside for total small business participation. Biofire Defense is a for-profit limited liability company...
- This is a federal contract award by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The $2,800,348.97 cost-plus-fixed-fee contract is for the development of environmental assays and has a completion date of July 29, 2022. The place of performance is Salt Lake City, UT. Biofire Defense has previously received other prime and...
- This $5,410,602.21 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Biofire Defense LLC, a manufacturer of biological agent identification products and diagnostic solutions. The contract has an ultimate completion date of December 18, 2026 and does not utilize a set-aside designation. The contract requires Biofire Defense to provide all necessary services, personnel, material, equipment, and facilities to add the Biofire...
- This is a $11,317.74 firm fixed price purchase order awarded by the Bureau of Administration, a civilian agency, to Biofire Defense LLC, a for-profit limited liability company. The contract is for the delivery of medical supplies with a completion date of September 28, 2024. There is no set-aside designation for this award. Biofire Defense has previously received other federal prime and subcontract awards as well as a $6.2 million cooperative agreement from the Department of Defense to expand...
- The U.S. Bureau of Medicine and Surgery awarded Biofire Defense LLC a firm fixed-price purchase order valued at $102,586.80 for FilmArray 2.0 Complete COVID-19 ECM (Extraction, Concentration, Mixing) kits. The contract was issued on April 28, 2020, with an ultimate completion date of November 30, 2020, to support the federal government's urgent response to the coronavirus pandemic. This award was designated as a National Interest Action related to COVID-19 and represents a direct procurement...
- This is a firm fixed-price delivery order contract awarded by the Joint PEO Chemical and Biological Defense, a defense agency, to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract, valued at $1,214,019.91, is for a feasibility study to migrate the Sentinel and Warrior Panels to other Biofire systems. Biofire Defense is a manufacturer of biological agent identification products and advanced diagnostic solutions for federal agencies. The...
This is a sole source, cost-plus-fixed-fee contract awarded by the U.S. Army Medical Research Acquisition Activity (USAMRAA) to BioFire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract, valued at $1,973,013.72, is for sample type expansion studies for BioFire Defense's COVID-19 test under Emergency Use Authorization. The objective is to increase the utility of the BioFire COVID-19 test system by studying anterior nares swab and saliva sample types. There is no set-aside designation for this contract. BioFire Defense is the only organization with the regulatory standing to submit an amendment to the existing Emergency Use Authorization for the COVID-19 test, which is used across approximately 1,000 FilmArray instruments deployed by the Department of Defense worldwide.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Sample Type Expansion Studies for the BioFire Defense COVID-19 Test under Emergency Use Authorization | W81XWH20R0104 | Department of the Army Medical Command | Pre-Solicitation 1/3 | 8/3/20, 2:38 PM | |
Justification and Approval: Sample Type Expansion Studies for the BioFire Defense COVID-19 Test under Emergency Use Authorization | JA-20-08-00193 | Department of the Army Medical Command | Limited / Sole Source Justification 3/3 | 10/28/20, 3:18 PM | |
Notice of Intent: Sample Type Expansion Studies for the BioFire Defense COVID-19 Test under Emergency Use Authorization | W81XWH20R0104 | Department of the Army Medical Command | Special Notice 2/3 | 8/17/20, 11:32 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00013 | Supplemental Agreement for work within scope | ($695k) | 3/26/25 | |
| P00012 | Supplemental Agreement for work within scope | $0 | 3/16/23 | |
| P00011 | Supplemental Agreement for work within scope | $0 | 12/19/22 | |
| P00010 | Supplemental Agreement for work within scope | $8.0k | 5/10/22 | |
| P00009 | Supplemental Agreement for work within scope | $274.1k | 4/4/22 |